Resilience Relocates Headquarters from San Diego to Ohio, Expands Sterile Injectable Manufacturing Capacity
核心洞察
Resilience (搜索), a leading biomanufacturing CDMO, is relocating its corporate headquarters from San Diego, California to Blue Ash, Ohio, strengthening its operational footprint in the state.
The new 450,000-square-foot Blue Ash site will serve as a drug product packaging and supply operation, with the company anticipating approximately 200 new jobs.
Resilience (搜索) is investing in a new Groninger multi-purpose injectable fill/finish line at its West Chester facility to expand sterile manufacturing capacity for biopharmaceutical partners.
Resilience (搜索), a North American contract development and manufacturing organization (CDMO) dedicated to broadening access to complex medicines, announced on June 18, 2026 the relocation of its corporate headquarters from San Diego, California to Blue Ash, Ohio, a northern suburb of Cincinnati. The announcement was made alongside Ohio Governor Mike DeWine, JobsOhio (搜索), the City of Blue Ash, and REDI Cincinnati (搜索), marking a significant shift in the company's operational strategy and reinforcing Ohio's emergence as a hub for pharmaceutical and sterile manufacturing innovation.
The new headquarters, located at 10901 Kenwood Road, anchors Resilience (搜索)'s growing Ohio-based sterile injectable manufacturing and packaging network. The move strategically positions the company near its existing 580,000-square-foot commercially licensed drug product facility in West Chester, Ohio, creating a highly integrated regional hub for sterile manufacturing, device assembly, packaging, and supply chain operations.
"We are happy to welcome Resilience (搜索) to Ohio, the latest in a long line of companies that have left the coasts to move to our state," said Governor Mike DeWine. "Resilience's decision to relocate its headquarters to Ohio shows that they have confidence in Ohio's skilled workforce, strong infrastructure, and growing leadership in advanced pharmaceutical manufacturing. This investment will create new opportunities for Ohioans while helping strengthen the domestic supply of critical medicines for patients across the country."
Blue Ash Site Capabilities and Workforce Expansion
Resilience (搜索)'s Blue Ash site will serve as a world-class drug product packaging and supply operation spanning more than 450,000 square feet. The facility's capabilities will include visual inspection, device assembly, packaging, labeling, and cold storage warehousing. The company anticipates adding approximately 200 new jobs in Blue Ash, with Ohio Life Sciences and regional workforce partners, including Butler Tech's cGMP biomanufacturing training program, helping build the skilled talent pipeline to support that growth.
Sterile Manufacturing Expansion in West Chester
In addition to the headquarters relocation, Resilience (搜索) announced its investment in a Groninger multi-purpose injectable fill/finish line at its West Chester, Ohio facility. The new line will expand the company's manufacturing capacity and capabilities, providing greater flexibility to support multiple injectable formats, product types, and commercial supply for biopharmaceutical partners.
"This relocation reflects our continued commitment to building a resilient, scaled manufacturing network in the United States," said William Marth, Resilience (搜索)'s President and Chief Executive Officer. "Ohio offers a strong manufacturing workforce, operational infrastructure, and proximity to many customers and partners. Establishing our headquarters in Blue Ash alongside continued investment in our sterile manufacturing and packaging capabilities positions us to better support the evolving needs of the industry."
Building on Prior Momentum
Today's announcement builds on the March 2025 expansion, when Resilience (搜索) and JobsOhio (搜索) announced continued investment in the company's Ohio operations, including device assembly and packaging capabilities in Blue Ash. The broader strategy aims to strengthen domestic manufacturing capacity for critical medicines and support a more resilient U.S. healthcare supply chain.
"Resilience (搜索)'s continued investment in Ohio reflects the strength of the state's advanced manufacturing industry and growing leadership in pharmaceutical production, further advancing life sciences within the Ohio Discovery Corridor," said JobsOhio (搜索) President and CEO J.P. Nauseef. "By choosing Southwest Ohio for its new headquarters and sterile manufacturing operations, Resilience is bolstering the nation's healthcare supply chain while creating high-quality jobs and long-term economic opportunity for the region."
Kimm Lauterbach, President and CEO of REDI Cincinnati (搜索), noted that the region's life sciences industry contributes more than $7.4 billion in gross regional product and is supported by nearly 1,300 business locations. Following two successful expansions and growth to nearly 1,000 employees, Resilience (搜索)'s headquarters relocation underscores the company's confidence in the region's skilled workforce and business climate.
An official ribbon-cutting ceremony and open house will be held at a later date, with members of the press, community leaders, and stakeholders invited to tour the new facility.
About Resilience (搜索)
Resilience (搜索) is a North American CDMO focused on delivering high-quality, scalable manufacturing solutions for advanced therapies. With capabilities spanning biologics drug substance, cell-based therapies, and aseptic drug product manufacturing for both small and large molecules, Resilience partners with leading biopharma companies to bring complex medicines to market faster and more reliably.